Overview

Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)

Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
An open label, randomized controlled trial of single vs. multiple treatments of praziquantel in intestinal African schistosomiasis in Côte d'Ivoire This study aims to determine the efficacy of repeated (up to four times) praziquantel treatment against S. mansoni infection in school-age children from Côte d'Ivoire using the traditional Kato-Katz thick smear technique, but also with more accurate and non-invasive antigen- and DNA-detection methods.
Phase:
Phase 3
Details
Lead Sponsor:
Leiden University Medical Center
Collaborators:
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Swiss Tropical & Public Health Institute
Treatments:
Praziquantel